Transgene SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 4.76 million compared to EUR 6.09 million a year ago. Net loss was EUR 15.9 million compared to EUR 15.28 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.244 EUR | +1.97% | +2.81% | -9.20% |
Apr. 10 | Transgene: presents vaccine results at AACR | CF |
Mar. 28 | Transgene CFO Steps Down; Successor Assumes Office | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.20% | 135M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- TNG Stock
- News Transgene
- Transgene SA Reports Earnings Results for the Half Year Ended June 30, 2023